Drug intelligence / Profile preview

Lyber-M

Development stage: Unknown
Lead developer: Anglo-French Drugs & Industries
Modality: Small Molecules
Administration: Oral

Overview

Lyber-M is a multi-ingredient nutraceutical supplement developed by Anglo-French Drugs & Industries (AFD Pharma) for the management of male infertility, specifically targeting conditions like oligospermia and asthenozoospermia. The formulation combines L-carnitine L-tartrate, Coenzyme Q10, zinc, lycopene, and folic acid to address the primary causes of reduced sperm quality. Its mechanism of action involves reducing oxidative stress through potent antioxidant activity, enhancing mitochondrial energy production to improve sperm motility, and providing essential micronutrients for healthy spermatogenesis and DNA integrity. By neutralizing reactive oxygen species (ROS), Lyber-M helps protect sperm cells from oxidative damage and fragmentation.

Brand names: Lyber-M
Other names: Lyber-M

Targets

CPT1A (Carnitine palmitoyltransferase 1A)ND1 (Mitochondrial electron transport chain complex I)

Beyond the preview

Go deeper on Lyber-M.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lyber-M.

Explore the full profile